Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lower Costs For Drug Review Personnel Are “Completely Normal” – FDA

Sep 02 2013

• By Derrick Gingery

Related Content

FDA Drug Review Costs Rise, But Personnel Spending Flattens

Aug 13 2012

PhRMA, BIO’s PDUFA V Application Tracker Could Inform “Course Corrections”

Jun 26 2013

Encore? FDA Could Come Close To Record 2012 NME Count This Year

Jul 29 2013

First-Cycle Approval Rate Already High; Can PDUFA V Actually Boost It?

May 06 2013

Additional Topics

United States Manufacturing Prescription To OTC Switch Regulation Drug Approval Standards OTC Drugs BioPharmaceutical Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window